Your browser doesn't support javascript.
loading
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
Deniffel, Dominik; Salinas, Emmanuel; Ientilucci, Marc; Evans, Andrew J; Fleshner, Neil; Ghai, Sangeet; Hamilton, Robert; Roberts, Alexander; Toi, Ants; van der Kwast, Theodorus; Zlotta, Alexandre; Finelli, Antonio; Haider, Masoom A; Perlis, Nathan.
Affiliation
  • Deniffel D; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Salinas E; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Ientilucci M; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Evans AJ; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Fleshner N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ghai S; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Hamilton R; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Roberts A; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Toi A; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • van der Kwast T; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Zlotta A; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Finelli A; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Haider MA; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Perlis N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
J Urol ; 204(6): 1187-1194, 2020 12.
Article in En | MEDLINE | ID: mdl-32496160

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatectomy / Prostatic Neoplasms / Magnetic Resonance Imaging, Interventional / Multiparametric Magnetic Resonance Imaging Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2020 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatectomy / Prostatic Neoplasms / Magnetic Resonance Imaging, Interventional / Multiparametric Magnetic Resonance Imaging Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2020 Type: Article Affiliation country: Canada